Atsushi Natsume

6PUBLICATIONS
29CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

|Dec 29, 2021
Microsatellite instability-high is rare events in refractory pediatric solid tumors.

Taro Yoshida, Hideki Muramatsu, Manabu Wakamatsu

|Jun 19, 2021
Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.

Yuki Ohkawa, Pu Zhang, Hiroyuki Momota

|May 06, 2020
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone.

Atsushi Natsume, Kosuke Aoki, Fumiharu Ohka

|Mar 26, 2018
Podoplanin: An emerging cancer biomarker and therapeutic target.

Harini Krishnan, Julie Rayes, Tomoyuki Miyashita

|Mar 21, 2018
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

Toshihiko Wakabayashi, Atsushi Natsume, Junki Mizusawa

Pageof 1

Frequent Collaborators

1 joint publications

Gary S Goldberg

1 joint publications

Koichi Furukawa

1 joint publications

Taro Yoshida

1 joint publications

Hideki Muramatsu